A cross-sectional study to assess the persistence of immunity after the administration of PCV13 in three different schedules introduced over the years in children in Taiwan and the impact of PCV13 immunization on nasopharyngeal carriage
Latest Information Update: 27 May 2020
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections; Streptococcal infections
- Focus Pharmacodynamics
- 27 May 2020 New trial record
- 22 May 2020 Results published in the Thorax